Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.

C H Gleiter, Ursula Gresser, Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature European Journal of Medical Research. ,vol. 7, pp. 435- 446 ,(2002)

H A Toque, C E Teixeira, F B M Priviero, R P Morganti, E Antunes, G De Nucci, Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets British Journal of Pharmacology. ,vol. 154, pp. 787- 796 ,(2009) , 10.1038/BJP.2008.141

Zhi-Cheng Jing, Zai-Xin Yu, Jie-Yan Shen, Bing-Xiang Wu, Kai-Feng Xu, Xian-Yang Zhu, Lei Pan, Zhuo-Li Zhang, Xue-Qin Liu, Yu-Shun Zhang, Xin Jiang, Nazzareno Galiè, None, Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 1723- 1729 ,(2011) , 10.1164/RCCM.201101-0093OC

Dan Henrohn, Anna Sandqvist, Hanna Egeröd, Mikael Hedeland, Lisa Wernroth, Ulf Bondesson, Gerhard Wikström, Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension Vascular Pharmacology. ,vol. 73, pp. 71- 77 ,(2015) , 10.1016/J.VPH.2015.04.010

Duan-zhen Zhang, Xian-yang Zhu, Jing Meng, Hong-mei Xue, Xiao-tang Sheng, Xiu-min Han, Chun-Sheng Cui, Qi-guang Wang, Po Zhang, Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension. International Journal of Cardiology. ,vol. 147, pp. 433- 437 ,(2011) , 10.1016/J.IJCARD.2010.04.093

Cleber E. Teixeira, Fernanda B. M. Priviero, R. Clinton Webb, Differential Effects of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Vardenafil, and Tadalafil in Rat Aorta Journal of Pharmacology and Experimental Therapeutics. ,vol. 316, pp. 654- 661 ,(2006) , 10.1124/JPET.105.092544

Olivier Sitbon, Marc Humbert, Xavier Jaïs, Vincent Ioos, Abdul M. Hamid, Steeve Provencher, Gilles Garcia, Florence Parent, Philippe Hervé, Gérald Simonneau, Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension Circulation. ,vol. 111, pp. 3105- 3111 ,(2005) , 10.1161/CIRCULATIONAHA.104.488486

Arne K. Andreassen, Ragnhild Wergeland, Svein Simonsen, Odd Geiran, Cecilia Guevara, Thor Ueland, N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. American Journal of Cardiology. ,vol. 98, pp. 525- 529 ,(2006) , 10.1016/J.AMJCARD.2006.02.061

Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch, Robyn J. Barst, Harrison W. Farber, Jonathan R. Lindner, Michael A. Mathier, Michael D. McGoon, Myung H. Park, Robert S. Rosenson, Lewis J. Rubin, Victor F. Tapson, John Varga, ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association Journal of the American College of Cardiology. ,vol. 53, pp. 1573- 1619 ,(2009) , 10.1016/J.JACC.2009.01.004

Horst Olschewski, Peter Haredza, Burcu Karadaş, Ralph T. Schermuly, Norbert Weissmann, Werner Seeger, Friedrich Grimminger, Hossein A. Ghofrani, Robert Voswinckel, Frank Reichenberger, Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. Journal of the American College of Cardiology. ,vol. 44, pp. 1488- 1496 ,(2004) , 10.1016/J.JACC.2004.06.060